CD44 and gastric adenocarcinoma: The role ofALX-4 expression was evaluated in CD44+GCSCs, isolated from MKN-45 gastric adenocarcinoma cell line, to determine the therapeutic effect of this protein, particularly for drug resistant tumors (25, 27).